In: Environmental Science and Pollution Research, 2000, vol. 7, no. 3, p. 135-143
|
In: Journal of General Internal Medicine, 2007, vol. 22, no. 5, p. 632-638
|
In: Behavioral Ecology, 2010, vol. 21, no. 2, p. 349-355
|
In: European Review of Agricultural Economics, 1993, vol. 20, no. 2, p. 199-221
|
In: ICES Journal of Marine Science, 2013, vol. 70, no. 4, p. 707-721
|
In: The B.E. Journal of Economic Analysis & Policy, 2009, vol. 9, no. 1, p. -
|
In: Geografiska Annaler: Series B, Human Geography, 2015, vol. 97, no. 2, p. 155–167
This article explores how discourses of threat concerning invasive alien species emerge and how ordinary citizens understand, receive and appropriate them. It explores the ambivalence of scientists and policy-makers using emotive or highly charged terms and vocabulary, arguing that many make strategic yet cautious use of fear to raise awareness. Based both on in-depth interviews of scientists...
|
In: Ecology Letters, 2013, p. -
We address criticism that the Transport, Establishment, Abundance, Spread, Impact (TEASI) framework does not facilitate objective mapping of risk assessment methods nor defines best practice. We explain why TEASI is appropriate for mapping, despite inherent challenges, and how TEASI offers considerations for best practices, rather than suggesting one best practice.
|
In: Ecology Letters, 2012, vol. 15, no. 12, p. 1475-1493
Some alien species cause substantial impacts, yet most are innocuous. Given limited resources, forecasting risks from alien species will help prioritise management. Given that risk assessment (RA) approaches vary widely, a synthesis is timely to highlight best practices. We reviewed quantitative and scoring RAs, integrating < 300 publications into arguably the most rigorous quantitative RA...
|
Thèse de doctorat : Università della Svizzera italiana, 2007 ; 2007COM009.
Medical decisions are paradigmatically uncertain. Awareness of this uncertainty at the policy level has produced a strict regulation of the information exchange related to medical issues, e.g. by means of the institute of the informed consent or through tight administrative norms regulating the pharmaceutical communication towards the public. As a special support of such sort of information,...
|